Optimized Rehabilitation of Older Adults With Hip Fracture and Signs of Cognitive Impairment - Feasibility Study
NCT ID: NCT06286722
Last Updated: 2025-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2024-02-08
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This feasibility study aims to assess the practicality and safety of implementing a 12-week individualized, progressive exercise program for older adults with hip fracture and cognitive impairment in an outpatient setting. Additionally, the investigators seek to gather qualitative insights through observations and interviews regarding participants' experiences and the perceived value of rehabilitation post-hip fracture, particularly focusing on the exercise intervention provided.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cross-sectoral Rehabilitation of Older High-risk Patients with Hip Fracture
NCT06304584
HIP Fracture REhabilitation Programme
NCT04207788
HIP Fracture REhabilitation Programme for Elderly With Hip Fractures
NCT03828240
Rehabilitation to Patients Over 65 Years Undergoing THA
NCT00226070
Progressive Resistance Training Versus Total Hip Arthroplasty in Patients With Hip Osteoarthritis
NCT04070027
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Progressive, individualized and structured exercise program
Individualized, progressive, structured exercise program. Participants will receive 12-weeks of either home-based and/or at a healthcare center intervention.
The "at home" intervention will consist of 3 visits/sessions per week (approximately 30-60 min.) for 12 weeks (maximum of 36 sessions in total) delivered in the participants own home, temporary home (e.g. 24- hour rehabilitation facility), nursing home or assisted living facilities.
The "at a healthcare center" intervention will be suggested to the participant when the physiotherapist and the participant feel confident that the participant can handle the transportation to/from the healthcare center, and will benefit from the higher intensity of the "at a healthcare center" intervention. This intervention consists of 2 visits/sessions per week (approximately 45-60 min.) for 12 weeks (total maximum of 24 sessions).
Progressive, individualized and structured exercise program
See description under Arms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Progressive, individualized and structured exercise program
See description under Arms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Independent pre-fracture ambulatory function (≥2 on the New Mobility Score on indoor walking)
* Having signs of cognitive impairment measured with the Mini-Mental Score Examination of \<24 points, or a verified dementia diagnosis, or on information from the patient record
* Living in their own home, nursing home, or assisted living facilities
* Informed consent by patient
Exclusion Criteria
* Having signs of severe dementia measured with the Mini-Mental State Examination (\<10 points)
* Non-Danish speaking
* Patients with an unstable health condition (e.g. not treated high blood pressure (\>180 mm HG)) evaluated by medical consultant
* "Safety concerns" (e.g. underlying comorbidities that might be associated with serious adverse events) - not safe to participate in the opinion of the investigator
* Having behavioral or psychotic disorders
* Alcohol or drug abuse
* Unable to participate in the intervention (e.g. due to blindness, no language)
* Patients with any weight-bearing restrictions after surgery
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vordingborg Municipality
UNKNOWN
Stevns Municipality
UNKNOWN
Guldborgsund Municipality
UNKNOWN
Frederiksberg Municipality
UNKNOWN
Horsholm Municipality
OTHER
Lolland Community, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mr. Jan Overgaard
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Trine Nordentoft
Role: STUDY_CHAIR
Vordingborg Municipality
Halil Baldan
Role: STUDY_CHAIR
Guldborgsund Municipality
Lotte Bylov
Role: STUDY_CHAIR
Stevns Municipality
Gwen Tremmel
Role: STUDY_CHAIR
Lolland Municipality
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Frederiksberg Healthcare center and 24-hour rehabilitation
Frederiksberg, , Denmark
Stevns Healthcare Center, Stevns Municipality
Hårlev, , Denmark
Hørsholm Health and Rehabilitation Center
Hørsholm, , Denmark
Maribo Health Center, Lolland Municipality
Maribo, , Denmark
Guldborgsund Healthcare Center, Guldborgsund Municipality
Nykøbing Falster, , Denmark
Vordingborg Healthcare Center, Vordingborg Municipality
Vordingborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LollandCD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.